In short. Some volume at the first session, a long effect and no dissolving agent. How this class behaves next to the others, and what each difference costs the patient.
Key points
- It buys a treatment that does not feel like nothing has happened on the day, which matters to patients who find the quiet weeks of a gradual course hard.
- It costs you the ability to judge early, and it means the shape you see in the first month is not the shape you keep.
The collagen-stimulating classes are often discussed as though they were variations on one treatment. They are not. Each behaves differently in the first month, holds for a different length of time, and leaves the patient with a different set of options if the result is not what they wanted. Three differences matter more than the rest.
The first session looks like a result
This substance is placed as microspheres suspended in a carrier gel, and the gel gives volume immediately. The area looks fuller within minutes of the first session, which no other stimulator class does in the same way. It is the most misleading part of the treatment, because it flatters the shape before anything has been laid down and it disappears over the following weeks. A patient who judges the course at that point, in either direction, is judging the carrier.
The effect lasts, and is judged late
The scaffold that remains after the carrier has gone persists, and the collagen built around it develops over months. The course is usually completed between three and six months, the effect continues to build after the last session, and the honest moment to judge the result is somewhere between six and eighteen months. That combination of a long effect and a late judgement is the reason this class suits a patient who is sure of what they want and frustrates one who is still deciding.
What the carrier buys you, and what it costs
It buys a treatment that does not feel like nothing has happened on the day, which matters to patients who find the quiet weeks of a gradual course hard. It costs you the ability to judge early, and it means the shape you see in the first month is not the shape you keep.
There is no way back
No injected enzyme reverses this substance. An uneven result, an asymmetry or an over-correction is addressed by observation, by massage, by an injected treatment or occasionally by removal, and it is never switched off. The other classes are not all reversible either, but a hyaluronic-acid filler is, and that difference is not a footnote. It is what determines whether the first session is a commitment or a test.
Where the comparison misleads
- Reading the early fullness as evidence that the substance works faster than it does.
- Assuming a longer effect is automatically better, when it is only better if the result is wanted.
- Choosing this class because it sounds stronger, without establishing what would happen if the result were uneven.
The practical consequence is that this class is chosen for two reasons: a patient who wants a change held for a long time, and an area where a gradual diffuse build suits the tissue. A patient who wants to see the result before committing to it, or who is unsure whether they want volume in that area at all, is better served by starting with the reversible option and treating this decision as the later one.
Frequently asked questions
Does the early volume make this substance easier to judge?
It makes it harder. The fullness on the day is the carrier rather than the effect, so the first session is misleading in a way that a substance without carrier volume is not. What you are judging in the first month is the gel, and it will not be there in that form later.
Why is there no dissolving agent for this substance?
Because the material is not a hyaluronic-acid gel and no enzyme breaks it down on request. The scaffold is cleared by the body slowly and on its own schedule. That is a property of the class rather than a limitation of a particular clinic or technique.
Does a longer-lasting substance mean better value?
Only if you are satisfied with the result. Duration is a benefit when the change is one you want held, and a problem when it is not, because there is no way to end it early. Value here depends entirely on whether the first assessment was right about what you wanted.
Risks & Limitations
- Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
- Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Bruising, swelling, tenderness and occasional headache after treatment.
- The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.